nodes	percent_of_prediction	percent_of_DWPC	metapath
Captopril—ABCB1—Topotecan—cervical cancer	0.0962	1	CbGbCtD
Captopril—LTA4H—exocrine gland—cervical cancer	0.0379	0.0636	CbGeAlD
Captopril—REN—exocrine gland—cervical cancer	0.0293	0.0491	CbGeAlD
Captopril—F2—Common Pathway—SERPIND1—cervical cancer	0.0274	0.0905	CbGpPWpGaD
Captopril—MMP2—exocrine gland—cervical cancer	0.0269	0.0451	CbGeAlD
Captopril—F2—Intrinsic Pathway—SERPIND1—cervical cancer	0.0233	0.0771	CbGpPWpGaD
Captopril—F2—Intrinsic Pathway—GP5—cervical cancer	0.0204	0.0674	CbGpPWpGaD
Captopril—LTA4H—uterine cervix—cervical cancer	0.0164	0.0274	CbGeAlD
Captopril—F2—Formation of Fibrin Clot (Clotting Cascade)—SERPIND1—cervical cancer	0.0157	0.052	CbGpPWpGaD
Captopril—LTA4H—decidua—cervical cancer	0.0156	0.0261	CbGeAlD
Captopril—LTA4H—renal system—cervical cancer	0.0153	0.0256	CbGeAlD
Captopril—LTA4H—endometrium—cervical cancer	0.0148	0.0248	CbGeAlD
Captopril—LTA4H—mammalian vulva—cervical cancer	0.0143	0.024	CbGeAlD
Captopril—F2—Formation of Fibrin Clot (Clotting Cascade)—GP5—cervical cancer	0.0138	0.0455	CbGpPWpGaD
Captopril—LTA4H—uterus—cervical cancer	0.0136	0.0229	CbGeAlD
Captopril—F2—Platelet Aggregation (Plug Formation)—GP5—cervical cancer	0.0135	0.0445	CbGpPWpGaD
Captopril—REN—epithelium—cervical cancer	0.0127	0.0213	CbGeAlD
Captopril—LTA4H—female reproductive system—cervical cancer	0.0123	0.0205	CbGeAlD
Captopril—REN—decidua—cervical cancer	0.012	0.0202	CbGeAlD
Captopril—REN—renal system—cervical cancer	0.0118	0.0198	CbGeAlD
Captopril—MMP2—epithelium—cervical cancer	0.0117	0.0196	CbGeAlD
Captopril—MMP2—uterine cervix—cervical cancer	0.0116	0.0195	CbGeAlD
Captopril—REN—endometrium—cervical cancer	0.0114	0.0191	CbGeAlD
Captopril—LTA4H—female gonad—cervical cancer	0.0112	0.0187	CbGeAlD
Captopril—LTA4H—vagina—cervical cancer	0.0111	0.0186	CbGeAlD
Captopril—MMP2—decidua—cervical cancer	0.0111	0.0185	CbGeAlD
Captopril—MMP2—renal system—cervical cancer	0.0109	0.0182	CbGeAlD
Captopril—F2—Complement and Coagulation Cascades—SERPIND1—cervical cancer	0.0106	0.035	CbGpPWpGaD
Captopril—MMP2—endometrium—cervical cancer	0.0105	0.0176	CbGeAlD
Captopril—MMP9—epithelium—cervical cancer	0.0102	0.0171	CbGeAlD
Captopril—MMP2—mammalian vulva—cervical cancer	0.0102	0.017	CbGeAlD
Captopril—MMP9—uterine cervix—cervical cancer	0.0101	0.0169	CbGeAlD
Captopril—MMP2—uterus—cervical cancer	0.00968	0.0162	CbGeAlD
Captopril—MMP9—decidua—cervical cancer	0.00962	0.0161	CbGeAlD
Captopril—REN—female reproductive system—cervical cancer	0.00946	0.0159	CbGeAlD
Captopril—MMP9—renal system—cervical cancer	0.00945	0.0158	CbGeAlD
Captopril—MMP9—endometrium—cervical cancer	0.00913	0.0153	CbGeAlD
Captopril—F2—epithelium—cervical cancer	0.00889	0.0149	CbGeAlD
Captopril—MMP2—female reproductive system—cervical cancer	0.0087	0.0146	CbGeAlD
Captopril—REN—female gonad—cervical cancer	0.00861	0.0144	CbGeAlD
Captopril—MMP9—uterus—cervical cancer	0.00842	0.0141	CbGeAlD
Captopril—MMP2—Direct p53 effectors—POU4F1—cervical cancer	0.00829	0.0274	CbGpPWpGaD
Captopril—F2—renal system—cervical cancer	0.00824	0.0138	CbGeAlD
Captopril—MMP2—female gonad—cervical cancer	0.00791	0.0133	CbGeAlD
Captopril—MMP2—vagina—cervical cancer	0.00787	0.0132	CbGeAlD
Captopril—SLC15A1—epithelium—cervical cancer	0.00757	0.0127	CbGeAlD
Captopril—MMP9—female reproductive system—cervical cancer	0.00756	0.0127	CbGeAlD
Captopril—LTA4H—lymph node—cervical cancer	0.00717	0.012	CbGeAlD
Captopril—SLC15A1—renal system—cervical cancer	0.00702	0.0118	CbGeAlD
Captopril—F2—Cell surface interactions at the vascular wall—GP6—cervical cancer	0.00701	0.0231	CbGpPWpGaD
Captopril—MMP9—female gonad—cervical cancer	0.00688	0.0115	CbGeAlD
Captopril—SLC15A1—endometrium—cervical cancer	0.00679	0.0114	CbGeAlD
Captopril—F2—female reproductive system—cervical cancer	0.0066	0.0111	CbGeAlD
Captopril—SLC15A1—mammalian vulva—cervical cancer	0.00657	0.011	CbGeAlD
Captopril—F2—PAR1-mediated thrombin signaling events—AKAP13—cervical cancer	0.0062	0.0205	CbGpPWpGaD
Captopril—F2—female gonad—cervical cancer	0.00601	0.0101	CbGeAlD
Captopril—MMP2—Syndecan-2-mediated signaling events—FGFR3—cervical cancer	0.00563	0.0186	CbGpPWpGaD
Captopril—ACE—epithelium—cervical cancer	0.00543	0.00909	CbGeAlD
Captopril—ACE—decidua—cervical cancer	0.00513	0.00859	CbGeAlD
Captopril—MMP2—lymph node—cervical cancer	0.00509	0.00853	CbGeAlD
Captopril—SLC15A1—vagina—cervical cancer	0.00509	0.00852	CbGeAlD
Captopril—ACE—renal system—cervical cancer	0.00503	0.00844	CbGeAlD
Captopril—ACE—endometrium—cervical cancer	0.00487	0.00816	CbGeAlD
Captopril—MMP2—ATF-2 transcription factor network—HES1—cervical cancer	0.00472	0.0156	CbGpPWpGaD
Captopril—ACE—mammalian vulva—cervical cancer	0.00471	0.00789	CbGeAlD
Captopril—MMP2—Developmental Biology—INSM1—cervical cancer	0.00469	0.0155	CbGpPWpGaD
Captopril—MMP9—lymph node—cervical cancer	0.00443	0.00742	CbGeAlD
Captopril—ACE—female reproductive system—cervical cancer	0.00403	0.00676	CbGeAlD
Captopril—F2—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00368	0.0122	CbGpPWpGaD
Captopril—ACE—female gonad—cervical cancer	0.00367	0.00615	CbGeAlD
Captopril—MMP2—Syndecan-2-mediated signaling events—CASP3—cervical cancer	0.00365	0.012	CbGpPWpGaD
Captopril—REN—Peptide hormone metabolism—CTNNB1—cervical cancer	0.00356	0.0118	CbGpPWpGaD
Captopril—MMP9—Syndecan-1-mediated signaling events—FGFR3—cervical cancer	0.00354	0.0117	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	0.00324	0.0107	CbGpPWpGaD
Captopril—F2—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00322	0.0106	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—INSM1—cervical cancer	0.00308	0.0102	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—CASP8—cervical cancer	0.00297	0.0098	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—CASP8—cervical cancer	0.00279	0.00923	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—FGFR3—cervical cancer	0.00267	0.00883	CbGpPWpGaD
Captopril—ALB—lymph node—cervical cancer	0.00246	0.00413	CbGeAlD
Captopril—CYP2D6—renal system—cervical cancer	0.00246	0.00413	CbGeAlD
Captopril—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARB—cervical cancer	0.00238	0.00786	CbGpPWpGaD
Captopril—F2—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.00236	0.0078	CbGpPWpGaD
Captopril—ACE—lymph node—cervical cancer	0.00236	0.00395	CbGeAlD
Captopril—MMP9—Endochondral Ossification—FGFR3—cervical cancer	0.00233	0.00771	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—CASP3—cervical cancer	0.0023	0.0076	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—CASP3—cervical cancer	0.00224	0.00742	CbGpPWpGaD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TERT—cervical cancer	0.00215	0.0071	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—cervical cancer	0.00213	0.00703	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—CASP3—cervical cancer	0.00211	0.00699	CbGpPWpGaD
Captopril—MMP9—TWEAK Signaling Pathway—CTNNB1—cervical cancer	0.00204	0.00673	CbGpPWpGaD
Captopril—CYP2D6—female reproductive system—cervical cancer	0.00197	0.00331	CbGeAlD
Captopril—MMP9—AGE/RAGE pathway—CASP8—cervical cancer	0.00195	0.00643	CbGpPWpGaD
Captopril—F2—Folate Metabolism—MTHFR—cervical cancer	0.00192	0.00635	CbGpPWpGaD
Captopril—ABCB1—epithelium—cervical cancer	0.00191	0.0032	CbGeAlD
Captopril—F2—Hemostasis—GP6—cervical cancer	0.0019	0.00628	CbGpPWpGaD
Captopril—F2—Hemostasis—SERPIND1—cervical cancer	0.0019	0.00628	CbGpPWpGaD
Captopril—ABCB1—uterine cervix—cervical cancer	0.00189	0.00317	CbGeAlD
Captopril—MMP2—AGE/RAGE pathway—STAT3—cervical cancer	0.00189	0.00623	CbGpPWpGaD
Captopril—MMP2—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	0.00186	0.00613	CbGpPWpGaD
Captopril—F2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00185	0.00611	CbGpPWpGaD
Captopril—ABCB1—decidua—cervical cancer	0.0018	0.00302	CbGeAlD
Captopril—LTA4H—Metabolism—CA9—cervical cancer	0.0018	0.00596	CbGpPWpGaD
Captopril—CYP2D6—female gonad—cervical cancer	0.0018	0.00301	CbGeAlD
Captopril—ABCB1—renal system—cervical cancer	0.00177	0.00297	CbGeAlD
Captopril—MMP2—Degradation of the extracellular matrix—CASP3—cervical cancer	0.00177	0.00584	CbGpPWpGaD
Captopril—MMP2—LPA receptor mediated events—EGFR—cervical cancer	0.00176	0.00581	CbGpPWpGaD
Captopril—MMP2—AGE/RAGE pathway—EGFR—cervical cancer	0.00171	0.00567	CbGpPWpGaD
Captopril—ABCB1—endometrium—cervical cancer	0.00171	0.00287	CbGeAlD
Captopril—F2—Hemostasis—GP5—cervical cancer	0.00166	0.00549	CbGpPWpGaD
Captopril—ABCB1—mammalian vulva—cervical cancer	0.00166	0.00278	CbGeAlD
Captopril—ABCB1—HIF-1-alpha transcription factor network—CA9—cervical cancer	0.00165	0.00544	CbGpPWpGaD
Captopril—MMP9—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—cervical cancer	0.00161	0.00533	CbGpPWpGaD
Captopril—ACE—Peptide hormone metabolism—CTNNB1—cervical cancer	0.00159	0.00525	CbGpPWpGaD
Captopril—ABCB1—uterus—cervical cancer	0.00158	0.00265	CbGeAlD
Captopril—F2—Selenium Micronutrient Network—MTHFR—cervical cancer	0.00153	0.00504	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—CASP3—cervical cancer	0.00151	0.00499	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—CASP3—cervical cancer	0.00147	0.00487	CbGpPWpGaD
Captopril—ALB—Platelet activation, signaling and aggregation—GP6—cervical cancer	0.00146	0.00483	CbGpPWpGaD
Captopril—MMP9—FGF signaling pathway—STAT3—cervical cancer	0.00145	0.0048	CbGpPWpGaD
Captopril—ABCB1—female reproductive system—cervical cancer	0.00142	0.00238	CbGeAlD
Captopril—F2—GPCR ligand binding—TAAR6—cervical cancer	0.00141	0.00465	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—CTNNB1—cervical cancer	0.00135	0.00448	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—MTOR—cervical cancer	0.00132	0.00436	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—CD4—cervical cancer	0.00132	0.00435	CbGpPWpGaD
Captopril—ABCB1—female gonad—cervical cancer	0.00129	0.00216	CbGeAlD
Captopril—ABCB1—vagina—cervical cancer	0.00128	0.00215	CbGeAlD
Captopril—ALB—Platelet activation, signaling and aggregation—GP5—cervical cancer	0.00128	0.00422	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—FGFR3—cervical cancer	0.00124	0.0041	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—STAT3—cervical cancer	0.00124	0.00409	CbGpPWpGaD
Captopril—MMP9—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—cervical cancer	0.00122	0.00402	CbGpPWpGaD
Captopril—MMP9—Degradation of the extracellular matrix—CASP3—cervical cancer	0.00116	0.00383	CbGpPWpGaD
Captopril—MMP9—LPA receptor mediated events—EGFR—cervical cancer	0.00115	0.00381	CbGpPWpGaD
Captopril—MMP9—AGE/RAGE pathway—EGFR—cervical cancer	0.00112	0.00372	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—WNT2—cervical cancer	0.0011	0.00363	CbGpPWpGaD
Captopril—MMP9—CXCR4-mediated signaling events—STAT3—cervical cancer	0.00102	0.00337	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—EGFR—cervical cancer	0.000939	0.0031	CbGpPWpGaD
Captopril—ALB—Vitamin B12 Metabolism—MTHFR—cervical cancer	0.000936	0.00309	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—CASP3—cervical cancer	0.000925	0.00306	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.000916	0.00303	CbGpPWpGaD
Captopril—MMP9—AP-1 transcription factor network—TP53—cervical cancer	0.000901	0.00298	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—HLA-DPB1—cervical cancer	0.000887	0.00293	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—MTOR—cervical cancer	0.000872	0.00288	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—HES1—cervical cancer	0.000862	0.00285	CbGpPWpGaD
Captopril—F2—GPCR ligand binding—WNT5A—cervical cancer	0.000832	0.00275	CbGpPWpGaD
Captopril—ABCB1—lymph node—cervical cancer	0.00083	0.00139	CbGeAlD
Captopril—MMP9—Validated targets of C-MYC transcriptional activation—TP53—cervical cancer	0.000818	0.0027	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—TAAR6—cervical cancer	0.000795	0.00263	CbGpPWpGaD
Captopril—MMP2—Direct p53 effectors—TP53—cervical cancer	0.000789	0.00261	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—MTHFR—cervical cancer	0.000762	0.00252	CbGpPWpGaD
Captopril—ALB—Hemostasis—GP6—cervical cancer	0.000754	0.00249	CbGpPWpGaD
Captopril—ALB—Hemostasis—SERPIND1—cervical cancer	0.000754	0.00249	CbGpPWpGaD
Captopril—MMP2—Extracellular matrix organization—CASP3—cervical cancer	0.000741	0.00245	CbGpPWpGaD
Captopril—LTA4H—Metabolism—MTHFR—cervical cancer	0.000732	0.00242	CbGpPWpGaD
Captopril—F2—Folate Metabolism—TP53—cervical cancer	0.000729	0.00241	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—TAAR6—cervical cancer	0.000722	0.00239	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—EGFR—cervical cancer	0.000706	0.00233	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—HLA-DQB1—cervical cancer	0.000693	0.00229	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—STAT3—cervical cancer	0.000674	0.00223	CbGpPWpGaD
Captopril—REN—Metabolism of proteins—CTNNB1—cervical cancer	0.000672	0.00222	CbGpPWpGaD
Captopril—ABCB1—HIF-1-alpha transcription factor network—TERT—cervical cancer	0.000666	0.0022	CbGpPWpGaD
Captopril—ALB—Hemostasis—GP5—cervical cancer	0.000659	0.00218	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—NOTCH1—cervical cancer	0.000651	0.00215	CbGpPWpGaD
Captopril—MMP9—Signaling by SCF-KIT—EGFR—cervical cancer	0.000613	0.00202	CbGpPWpGaD
Captopril—ALB—Selenium Micronutrient Network—MTHFR—cervical cancer	0.000605	0.002	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—cervical cancer	0.000598	0.00198	CbGpPWpGaD
Captopril—MMP9—Spinal Cord Injury—TP53—cervical cancer	0.000593	0.00196	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—HES1—cervical cancer	0.000566	0.00187	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—WNT2—cervical cancer	0.000564	0.00186	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TAAR6—cervical cancer	0.000552	0.00183	CbGpPWpGaD
Captopril—F2—GPCR downstream signaling—AKAP13—cervical cancer	0.000545	0.0018	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—AKAP13—cervical cancer	0.000495	0.00164	CbGpPWpGaD
Captopril—MMP9—Extracellular matrix organization—CASP3—cervical cancer	0.000486	0.00161	CbGpPWpGaD
Captopril—MMP2—Axon guidance—EGFR—cervical cancer	0.00048	0.00159	CbGpPWpGaD
Captopril—F2—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.000453	0.0015	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CASP8—cervical cancer	0.000452	0.00149	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—CTNNB1—cervical cancer	0.000432	0.00143	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—WNT2—cervical cancer	0.000431	0.00143	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—WNT5A—cervical cancer	0.000427	0.00141	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—NOTCH1—cervical cancer	0.000427	0.00141	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TAAR6—cervical cancer	0.000427	0.00141	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—AKAP13—cervical cancer	0.000379	0.00125	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—STAT3—cervical cancer	0.000377	0.00125	CbGpPWpGaD
Captopril—MMP2—Developmental Biology—EGFR—cervical cancer	0.000343	0.00113	CbGpPWpGaD
Captopril—ABCB1—Allograft Rejection—CASP3—cervical cancer	0.000342	0.00113	CbGpPWpGaD
Captopril—F2—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000338	0.00112	CbGpPWpGaD
Captopril—MMP2—Metabolism of proteins—CTNNB1—cervical cancer	0.000334	0.0011	CbGpPWpGaD
Captopril—F2—Signaling Pathways—WNT2—cervical cancer	0.000333	0.0011	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—WNT5A—cervical cancer	0.000327	0.00108	CbGpPWpGaD
Captopril—MMP9—Axon guidance—EGFR—cervical cancer	0.000315	0.00104	CbGpPWpGaD
Captopril—ACE—Metabolism of proteins—CTNNB1—cervical cancer	0.0003	0.000992	CbGpPWpGaD
Captopril—F2—Signaling Pathways—AKAP13—cervical cancer	0.000292	0.000966	CbGpPWpGaD
Captopril—ALB—Folate Metabolism—TP53—cervical cancer	0.000289	0.000956	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—CTNNB1—cervical cancer	0.000284	0.000937	CbGpPWpGaD
Captopril—F2—Signaling Pathways—WNT5A—cervical cancer	0.000252	0.000834	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—STAT3—cervical cancer	0.000247	0.000817	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH2—cervical cancer	0.000229	0.000758	CbGpPWpGaD
Captopril—MMP9—Developmental Biology—EGFR—cervical cancer	0.000225	0.000743	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—cervical cancer	0.000223	0.000738	CbGpPWpGaD
Captopril—Dermatitis bullous—Topotecan—cervical cancer	0.000221	0.0495	CcSEcCtD
Captopril—Anaphylactoid reaction—Topotecan—cervical cancer	0.000218	0.0489	CcSEcCtD
Captopril—Cardiac arrest—Topotecan—cervical cancer	0.000201	0.045	CcSEcCtD
Captopril—MMP9—Signaling Pathways—HES1—cervical cancer	0.000188	0.000622	CbGpPWpGaD
Captopril—F2—Signaling Pathways—NOTCH2—cervical cancer	0.000177	0.000585	CbGpPWpGaD
Captopril—Pancytopenia—Topotecan—cervical cancer	0.000173	0.0388	CcSEcCtD
Captopril—Neutropenia—Topotecan—cervical cancer	0.000171	0.0382	CcSEcCtD
Captopril—F2—Metabolism of proteins—CTNNB1—cervical cancer	0.000169	0.000558	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—cervical cancer	0.000169	0.000558	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TERT—cervical cancer	0.000165	0.000545	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—cervical cancer	0.000163	0.000538	CbGpPWpGaD
Captopril—Stomatitis—Topotecan—cervical cancer	0.000158	0.0355	CcSEcCtD
Captopril—MMP9—Signaling Pathways—FGFR3—cervical cancer	0.000151	0.0005	CbGpPWpGaD
Captopril—ALB—Metabolism—CA9—cervical cancer	0.000149	0.000493	CbGpPWpGaD
Captopril—Rhinitis—Topotecan—cervical cancer	0.000146	0.0328	CcSEcCtD
Captopril—F2—Signaling Pathways—HES1—cervical cancer	0.000145	0.00048	CbGpPWpGaD
Captopril—Pharyngitis—Topotecan—cervical cancer	0.000145	0.0325	CcSEcCtD
Captopril—F2—Hemostasis—TP53—cervical cancer	0.000143	0.000472	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—NOTCH1—cervical cancer	0.000142	0.000469	CbGpPWpGaD
Captopril—ABCB1—Metabolism—CA9—cervical cancer	0.000131	0.000432	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000129	0.000426	CbGpPWpGaD
Captopril—Alopecia—Topotecan—cervical cancer	0.000129	0.0289	CcSEcCtD
Captopril—F2—Signaling Pathways—TERT—cervical cancer	0.000127	0.000421	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—CA9—cervical cancer	0.000123	0.000407	CbGpPWpGaD
Captopril—Ill-defined disorder—Topotecan—cervical cancer	0.000118	0.0264	CcSEcCtD
Captopril—Anaemia—Topotecan—cervical cancer	0.000117	0.0263	CcSEcCtD
Captopril—F2—Signaling Pathways—FGFR3—cervical cancer	0.000117	0.000386	CbGpPWpGaD
Captopril—Angioedema—Topotecan—cervical cancer	0.000116	0.026	CcSEcCtD
Captopril—Malaise—Topotecan—cervical cancer	0.000115	0.0257	CcSEcCtD
Captopril—Cough—Topotecan—cervical cancer	0.000111	0.0249	CcSEcCtD
Captopril—F2—Signaling Pathways—NOTCH1—cervical cancer	0.00011	0.000362	CbGpPWpGaD
Captopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000108	0.000358	CbGpPWpGaD
Captopril—Arthralgia—Topotecan—cervical cancer	0.000108	0.0243	CcSEcCtD
Captopril—Chest pain—Topotecan—cervical cancer	0.000108	0.0243	CcSEcCtD
Captopril—Myalgia—Topotecan—cervical cancer	0.000108	0.0243	CcSEcCtD
Captopril—Discomfort—Topotecan—cervical cancer	0.000107	0.024	CcSEcCtD
Captopril—MMP9—Signaling Pathways—MTOR—cervical cancer	0.000106	0.000352	CbGpPWpGaD
Captopril—Anaphylactic shock—Topotecan—cervical cancer	0.000104	0.0233	CcSEcCtD
Captopril—Thrombocytopenia—Topotecan—cervical cancer	0.000102	0.0228	CcSEcCtD
Captopril—Anorexia—Topotecan—cervical cancer	9.88e-05	0.0222	CcSEcCtD
Captopril—MMP9—Signaling Pathways—CASP3—cervical cancer	9.79e-05	0.000323	CbGpPWpGaD
Captopril—F2—Signaling by GPCR—EGFR—cervical cancer	9.77e-05	0.000323	CbGpPWpGaD
Captopril—Musculoskeletal discomfort—Topotecan—cervical cancer	9.45e-05	0.0212	CcSEcCtD
Captopril—MMP9—Signaling Pathways—CTNNB1—cervical cancer	9.43e-05	0.000312	CbGpPWpGaD
Captopril—Paraesthesia—Topotecan—cervical cancer	9.31e-05	0.0209	CcSEcCtD
Captopril—Dyspnoea—Topotecan—cervical cancer	9.24e-05	0.0207	CcSEcCtD
Captopril—Dyspepsia—Topotecan—cervical cancer	9.13e-05	0.0205	CcSEcCtD
Captopril—Decreased appetite—Topotecan—cervical cancer	9.01e-05	0.0202	CcSEcCtD
Captopril—Fatigue—Topotecan—cervical cancer	8.94e-05	0.0201	CcSEcCtD
Captopril—Constipation—Topotecan—cervical cancer	8.87e-05	0.0199	CcSEcCtD
Captopril—Feeling abnormal—Topotecan—cervical cancer	8.54e-05	0.0192	CcSEcCtD
Captopril—Gastrointestinal pain—Topotecan—cervical cancer	8.48e-05	0.019	CcSEcCtD
Captopril—MMP9—Signaling Pathways—STAT3—cervical cancer	8.22e-05	0.000272	CbGpPWpGaD
Captopril—F2—Signaling Pathways—MTOR—cervical cancer	8.22e-05	0.000271	CbGpPWpGaD
Captopril—Body temperature increased—Topotecan—cervical cancer	8.2e-05	0.0184	CcSEcCtD
Captopril—Abdominal pain—Topotecan—cervical cancer	8.2e-05	0.0184	CcSEcCtD
Captopril—F2—Signaling Pathways—CASP3—cervical cancer	7.56e-05	0.00025	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—EGFR—cervical cancer	7.47e-05	0.000247	CbGpPWpGaD
Captopril—Asthenia—Topotecan—cervical cancer	7.44e-05	0.0167	CcSEcCtD
Captopril—Pruritus—Topotecan—cervical cancer	7.34e-05	0.0165	CcSEcCtD
Captopril—F2—Signaling Pathways—CTNNB1—cervical cancer	7.28e-05	0.000241	CbGpPWpGaD
Captopril—Diarrhoea—Topotecan—cervical cancer	7.09e-05	0.0159	CcSEcCtD
Captopril—Dizziness—Topotecan—cervical cancer	6.86e-05	0.0154	CcSEcCtD
Captopril—Vomiting—Topotecan—cervical cancer	6.59e-05	0.0148	CcSEcCtD
Captopril—Rash—Topotecan—cervical cancer	6.54e-05	0.0147	CcSEcCtD
Captopril—Dermatitis—Topotecan—cervical cancer	6.53e-05	0.0147	CcSEcCtD
Captopril—Headache—Topotecan—cervical cancer	6.5e-05	0.0146	CcSEcCtD
Captopril—F2—Signaling Pathways—STAT3—cervical cancer	6.35e-05	0.00021	CbGpPWpGaD
Captopril—MMP9—Signaling Pathways—TP53—cervical cancer	6.27e-05	0.000207	CbGpPWpGaD
Captopril—Nausea—Topotecan—cervical cancer	6.16e-05	0.0138	CcSEcCtD
Captopril—ALB—Metabolism—MTHFR—cervical cancer	6.06e-05	0.0002	CbGpPWpGaD
Captopril—F2—Signaling Pathways—EGFR—cervical cancer	5.77e-05	0.000191	CbGpPWpGaD
Captopril—ALB—Hemostasis—TP53—cervical cancer	5.67e-05	0.000187	CbGpPWpGaD
Captopril—ABCB1—Metabolism—MTHFR—cervical cancer	5.31e-05	0.000175	CbGpPWpGaD
Captopril—CYP2D6—Metabolism—MTHFR—cervical cancer	5e-05	0.000165	CbGpPWpGaD
Captopril—F2—Signaling Pathways—TP53—cervical cancer	4.84e-05	0.00016	CbGpPWpGaD
